Andreas Herrmann

City:

Pfeffingen

Country:

Switzerland

Published Applications:

Last publication date:

2021-05-06

Top Assignees for applications by Andreas Herrmann

The entities that hold a legal rights for patent applications filed by inventor Herrmann Andreas:

BALIOPHARM AG 3 Basel, Switzerland
Probiocon GmbH 2 Pfeffingen, Switzerland
UNIVERSITÄT STUTTGART 1 Stuttgart, Germany
BALIOPHARMA AG 1 Basel, Switzerland

Recent patent applications by Herrmann Andreas

Andreas Herrmann from Pfeffingen, CH has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2021-05-06

US20210128722A1

Human necessities

RANKL-specific agent for treating metastatic disease

#2 | 2020-09-24

US20200299396A1

Chemistry; metallurgy

Method of treating nonalcoholic steatohepatitis by administering an antagonist human tumor necrosis factor receptor 1 (HUTNFR1) antibody

#3 | 2019-07-18

US20190218302A1

Chemistry; metallurgy

ANTI-CANCER COMBINATION TREATMENT

#4 | 2019-05-16

US20190144555A1

Chemistry; metallurgy

Monovalent anti-huTNFR1 antibodies, encoding nucleic acids thereof and methods of treatment thereof

#5 | 2017-11-09

US20170319687A1

Human necessities

RANKL-specific agent for treating metastatic disease

#6 | 2015-10-01

US20150274833A1

Chemistry; metallurgy

Recombinant bispecific antibody binding to CD20 and CD95

#7 | 2013-09-26

US20130251707A1

Chemistry; metallurgy

Anti-huTNFR1 antibody and methods of use thereof for treatment

InventorID:

455121 ⎘